+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease



Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease



Nephrology, Dialysis, Transplantation 25(4): 1183-1191



Uraemic toxins are considered to be emerging mortality risk factors in chronic kidney disease (CKD) patients. p-Cresol (a prototype protein-bound uraemic retention solute) has been shown to exert toxic effects in vitro. Recently, it has been demonstrated that p-cresol is present in plasma as its sulphate conjugate, p-cresylsulphate. The present study evaluated the distribution of free and total p-cresylsulphate and sought to determine whether these parameters were associated with vascular calcification, arterial stiffness and mortality risk in a cohort of CKD patients. One hundred and thirty-nine patients (mean +/- SD age: 67 +/- 12; males: 60%) at different stages of CKD (8% at Stage 2, 26.5% at Stage 3, 26.5% at Stage 4, 7% at Stage 5 and 32% at Stage 5D) were enrolled in this study. Baseline total and free p-cresylsulphate presented an inverse relationship with renal function and were significantly associated with vascular calcification. During the study period (mean follow-up period: 779 +/- 185 days), 38 patients died [including 22 from cardiovascular (CV) causes]. In crude survival analyses, free (but not total) p-cresylsulphate was shown to be a predictor of overall and CV death. Higher free p-cresylsulphate levels (>0.051 mg/100 mL; median) were associated with mortality independently of well-known predictors of survival such as age, vascular calcification, anaemia and inflammation. Serum levels of free and total p-cresylsulphate (the main in vivo circulating metabolites of p-cresol) were elevated in later CKD stages. However, only free p-cresylsulphate seems to be a predictor of survival in CKD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053299496

Download citation: RISBibTeXText

PMID: 19914995

DOI: 10.1093/ndt/gfp592


Related references

Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease. Clinical and Experimental Hypertension 38(5): 476-481, 2016

Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease. Aging Male 22(1): 62-67, 2018

Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. Bmc Nephrology 14(): 280-280, 2014

Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. Journal of Renal Nutrition 23(2): 106-113, 2013

Ankle-brachial index as a predictor for mortality in patients with chronic kidney disease and hemodialysis. Nephrology, 2009

Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease. Journal of Nephrology 28(6): 701-708, 2016

Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis. Nephrology 15(3): 294-299, 2010

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients. Plos One 12(12): E0186659-E0186659, 2017

Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis. Therapeutic Apheresis and Dialysis 17(6): 625-630, 2014

Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4. Current Medical Research and Opinion 28(9): 1527-1536, 2013

Statin use in patients with chronic kidney disease stages 2-4: targeting beyond improved mortality rates. International Urology and Nephrology 42(3): 711-713, 2011

Do Implantable Cardioverter Defibrillators Reduce Mortality in Patients With Chronic Kidney Disease at All Stages?. International Heart Journal 58(3): 371-377, 2017

Global Longitudinal Strain is a Superior Predictor of All-cause Mortality When Compared to Ejection Fraction in Patients with Mild to Moderate Chronic Kidney Disease. Heart Lung & Circulation 22: S180-S181, 2013

Tissue Doppler-derived E/e' ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease. Korean Journal of Internal Medicine 28(1): 35-44, 2013

Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease. Clinical Kidney Journal 11(3): 372-376, 2018